CG
Carter Gould Cantor Fitzgerald Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
22
Avg Return
Past Year
Past Year
6.8%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past Year
Positive
68.2%
Neutral
31.8%
Negative
0%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Mega Cap
Over $200B
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Consumer Staples
Healthcare
Technology
Consumer Staples
Education & Training Services
Healthcare
Biotechnology
Drug Manufacturers - General
Drug Manufacturers - Specialty & Generic
Technology
Software - Application
| Stock | Rating | Price Target |
Upside Downside |
Ratings 1 Year |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Overweight
Maintained
| $245 |
6%
upside
| 2 | +17% |
0
%
| 15 Sep ‘25 1 month ago |
|
|
|
Overweight
Maintained
| $825 |
3%
upside
| 3 | +0.03% |
0
%
| 13 Aug ‘25 2 months ago |
|
|
|
Overweight
Maintained
| $485 |
16%
upside
| 3 | -4% |
0
%
| 5 Aug ‘25 2 months ago |
|
|
|
Neutral
Reiterated
| $305 |
1%
upside
| 1 | – |
–
| 24 Jun ‘25 3 months ago |
|
|
|
Neutral
Reiterated
| $55 |
25%
upside
| 2 | +9.3% |
–
| 23 Apr ‘25 6 months ago |
|
|
|
Overweight
Assumed
| $695 |
20%
upside
| 3 | -14% |
0
%
| 22 Apr ‘25 6 months ago |
|
|
|
Neutral
Initiated
| $24 |
3%
downside
| 1 | – |
–
| 22 Apr ‘25 6 months ago |
|
|
|
Overweight
Initiated
| – | – | 1 | +41% |
0
%
| 22 Apr ‘25 6 months ago |
|
|
|
Neutral
Initiated
| $85 |
2%
downside
| 1 | -29% |
–
| 22 Apr ‘25 6 months ago |
|
|
|
Overweight
Assumed
| $125 |
1%
upside
| 2 | +18% |
0
%
| 22 Apr ‘25 6 months ago |
|
|
|
Overweight
Maintained
| $165 |
17%
upside
| 1 | +4.3% |
0
%
| 23 Dec ‘24 10 months ago |
|
|
|
Overweight
Maintained
| $20 |
29%
downside
| 1 | +59% |
0
%
| 1 Nov ‘24 11 months ago |
|
|
|
Equal-Weight
Maintained
| $180 |
23%
upside
| 1 | – |
–
| 31 Oct ‘24 11 months ago |
|